SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-082181
Filing Date
2016-02-16
Accepted
2016-02-16 11:35:29
Documents
59
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v430207_10q.htm 10-Q 288350
2 EXHIBIT 10.1 v430207_ex10-1.htm EX-10.1 83171
3 EXHIBIT 31.1 v430207_ex31-1.htm EX-31.1 11516
4 EXHIBIT 31.2 v430207_ex31-2.htm EX-31.2 11672
5 EXHIBIT 32.1 v430207_ex32-1.htm EX-32.1 5350
6 EXHIBIT 32.2 v430207_ex32-2.htm EX-32.2 5366
  Complete submission text file 0001144204-16-082181.txt   3430271

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT antb-20151231.xml EX-101.INS 583138
8 XBRL TAXONOMY EXTENSION SCHEMA antb-20151231.xsd EX-101.SCH 41824
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE antb-20151231_cal.xml EX-101.CAL 37568
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE antb-20151231_def.xml EX-101.DEF 287858
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE antb-20151231_lab.xml EX-101.LAB 315211
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE antb-20151231_pre.xml EX-101.PRE 317296
Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 650-847-1919
AntriaBio, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-54495 | Film No.: 161424941
SIC: 2834 Pharmaceutical Preparations